Peptides

Kallikrein-2 inhibitor, cyclic (KLK2b ht2) -1mg

162.00
Check your price
  • Cat.Number : AS-65651
  • Availability :
    In production

Quantity

KLK2b ht2, a head to tail cyclic peptide, is an inhibitor of human glandular kallikrein enzyme, kallikrein-2 (KLK2). This enzyme belongs to kallikreins, serine protease family, which comprises of 15 members (KLK1-KLK15). KLK2 is increased in tumor tissues and in serum of patients with prostate cancer and is considered as a biomarker for this type of cancer.
Inhibition of KLK2 activity might be a promising therapy for prostate cancer. KLK2b ht2 cyclic peptide shows higher stability and biological activity compared with linear peptide inhibitors.

Specifications

Chemistry
Sequence one letter code
  • Cyclo-ARFKVWWAN
Sequence three letter code
  • Cyclo-Ala-Arg-Phe-Lys-Val-Trp-Trp-Ala-Asn
Molecular Mass/ Weight
  • 1159.4
Modification
Conjugation
  • Unconjugated
Quantity & Purity
Purity
Storage & stability
Form
  • Lyophilized
Storage Conditions
  • - 20 °C
Activity
Biomarker Target
Research Area
Sub-category Research Area
Usage
  • Research use
Codes
Code Nacres
  • NA.36

You may also be interested in the following product(s)

IMG-EN-AS-65652-01.jpg

Kallikrein-2 inhibitor, cyclic (KLK2b ht4) -1mg

Cat.Number : AS-65652
162.00 Excl. Tax